Family Nurse Practitioner Exam

Which agent is NOT used to control inflammatory changes in asthmatics?

1. Albuterol inhaler (Proventil)

2. Triamcinolone (Azmacort)

3. Montelukast (Singulair)

4. Cromolyn sodium inhaler (Intal)

The correct answer is: Albuterol inhaler (Proventil)

The correct response indicates that the albuterol inhaler (Proventil) is not primarily used to control inflammatory changes in asthmatics. Albuterol is classified as a short-acting beta-agonist (SABA) and is primarily utilized for its bronchodilator effects, providing rapid relief of acute asthma symptoms by relaxing the muscles around the airways. While it is effective in relieving bronchospasm during an asthma attack, it does not address the underlying inflammation that characterizes asthma. In contrast, the other agents mentioned directly target inflammatory processes. Triamcinolone (Azmacort), for example, is an inhaled corticosteroid that reduces inflammation in the airways, thus helping to manage asthma over the long term. Montelukast (Singulair) works as a leukotriene receptor antagonist, preventing the effects of inflammatory mediators that contribute to asthma symptoms. Lastly, Cromolyn sodium inhaler (Intal) serves as a mast cell stabilizer, reducing the release of histamine and other inflammatory mediators that can precipitate asthma attacks. Overall, understanding the role of various medications in asthma management is crucial. The distinction between bronchodilators like albuterol and anti-inflammatory agents underscores the importance of comprehensive asthma treatment